Eisai Pharma Unveils Bold Plan: $100 Million Global Center Set to Transform Visakhapatnam Now
Eisai Pharma, a global leader in human health care, has announced its ambitious move to launch a state-of-the-art Global Capability Center (GCC) in Visakhapatnam. This strategic leap is expected to accelerate digital transformation in India’s pharmaceutical landscape, with robust backing from the Government of Andhra Pradesh and the Visakhapatnam Special Economic Zone.
Makoto Haketsu, Eisai’s Global Chief Information Officer, revealed this high-impact initiative during a visit to GITAM University, highlighting the company’s intent to harness the region’s exceptional digital talent. By tapping into local expertise, Eisai aims to deliver cutting-edge solutions for the rapidly evolving healthcare sector.
Haketsu praised GITAM’s innovative research environment and its focus on emerging technologies, noting the potential for deep academic-industry partnerships. With senior university figures and Eisai executives in attendance, both parties expressed strong interest in collaborative research—particularly in data science, healthcare technologies, and pharmaceutical breakthroughs.
Visakhapatnam MP M. Sribharat emphasized the city’s growing reputation for innovation-driven education and real-world impact. The new GCC is poised to create significant opportunities for joint technology development and foster a culture of continuous innovation.
Eisai’s latest move signals a major step in integrating digital innovation with healthcare, positioning Visakhapatnam as a future-ready hub for the next wave of pharmaceutical advancements. Don’t miss out on this transformative development in India’s pharma industry!
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Titan Technology Makes Bold Move with 55.85 Million Yuan Acquisition of UK Biochemical Firm ASL — What's Behind the Deal?
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
Wanhua Chemical's Hungarian 650,000-ton MDI/TDI Plant to Shut Down for 35-Day Maintenance
-
Beiersdorf Delivers 2025 Growth Despite Ongoing Market Pressure
-
Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?
-
BASF Battles Market Turmoil as Profits Slide
-
Cadmium Sulfide Uses: Pigments, Semiconductors & Safety Tips
-
Symrise Launches “Care & Wellness” Division to Strengthen Beauty–Health Integration
-
IMCD to Acquire 100% of Italian Coatings Distributor Tillmanns
-
China National Salt Industry Corporation Advances 10,000 t/y Sodium Metal Expansion Project, Industry Leader Invests Nearly RMB 100 Million
Recommend Reading
-
Indonesia Forges a Green Future for Its Highly Dynamic Packaging & Automotive Industries
-
Mitsubishi Gas Chemical Halts MXDA Plant Construction in the Netherlands Amid Rising Costs and Market Pressures
-
Univar Solutions Expands EMEA Portfolio Through Exclusive Distribution Agreement with CABB Group
-
Record Net Profit, Yet “Joining Forces” with a Rival? Axalta Drops a Final Trump Card Before the Merger
-
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
ECHEMI High Quality Inquiries (4-8 Aug)
-
Magnesium Stearate in Supplements: Is it Safe? (Vegan Status & Function)
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
Cost Benefits Support PTA Market’s “Strong Start”
-
Cost Benefits Boost Polyester Staple Fiber Market to a Strong Start